Aplastic Anemia and Hypoplastic MDS: A Diagnostic and Treatment Dilemma | Aplastic Anemia & MDS International Foundation

Aplastic Anemia and Hypoplastic MDS: A Diagnostic and Treatment Dilemma

Presenter(s): 
Topic(s): 
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presentation Date: 
Wednesday, August 26, 2020

Tiffany N. Tanaka, MD, is a board-certified hematologist specializing in the diagnosis and treatment of blood cancers and blood disorders, with an emphasis on myeloid malignancies.  Dr. Tanaka provides an overview of the diagnostic and treatment considerations for patients who have aplastic anemia and hypoplastic MDS.  This overlapping set of bone marrow failure diseases raises critical questions for patients and health care professionals.